NCT07153822View on ClinicalTrials.gov

Efficacy and Safety of Ionized Atelocollagen Adhesion Barrier (Collabarrier®) in Spine Surgery

NACompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

January 29, 2024

Study Completion Date

January 29, 2024

Conditions
Lumbar Spinal StenosisLumbar Disc HerniationEpidural FibrosisPostoperative Adhesion
Interventions
DEVICE

Collagen-based adhesion barrier

Porcine Atelocollagen (Type I)

DEVICE

Sodium hyaluronate(HA) and Sodium Carboxymethylcellulose(CMC)-based adhesion barrier

Sodium Hyaluronate(HA) + Sodium Carboxymethylcellulose(CMC)

Trial Locations (6)

Unknown

Ajou University Hospital, Seoul

Asan Medical Center, Seoul

Korea University Anam Hospital, Seoul

The Catholic University of Korea Eunpyeong St. Mary's Hospital, Seoul

The Catholic University of Korea Seoul St. Mary's Hospital, Seoul

The Catholic University of Korea St. Vincent's Hospital, Seoul

All Listed Sponsors
lead

DALIM TISSEN Co., Ltd.

INDUSTRY